June 29, 2026 · Form 4 insider transaction
Azelby Robert bought 47,500 shares of Autolus Therapeutics plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Share options vest in twelve equal monthly installments commencing on July 29, 2026.